Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients

@article{Kawada2009NegativeEO,
  title={Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients},
  author={Noritaka Kawada and Toshiki Moriyama and Naotsugu Ichimaru and Ryoichi Imamura and Isao Matsui and Yoshitsugu Takabatake and Yasuyuki Nagasawa and Yoshitaka Isaka and Yasuyuki Kojima and Yukito Kokado and Hiromi Rakugi and Enyu Imai and Shiro Takahara},
  journal={Clinical and Experimental Nephrology},
  year={2009},
  volume={13},
  pages={355-360}
}
Anemia is a common complication in posttransplant patients (posttransplant anemia: PTA). We tested the hypothesis that targeting hemoglobin (Hb) over 13.3 g/dl by administration of recombinant human erythropoietin (rHuEPO-ad) has positive impact on quality of life (QOL). Twenty-four patients, whose initial Hb and estimated glomerular filtration rate (eGFR) were 10.5 ± 0.2 g/dl and 48.5 ± 2.7 ml/(min 1.73 m2), respectively, were enrolled in the present study. Physical and mental QOL in these… CONTINUE READING